Table 3.

Comparative analysis between genotype frequencies and the risk of lung cancer in the subgroups of females

Female	Genotype	Cases (n = 104)	Controls (n = 105)	OR (95% CI)	p-value	asOR (95% CI)a	p-value
-3444 C>T	CC	35	39	1		1
	CT	50	58	0.96 (0.53 – 1.74)	0.89	0.94 (0.51 – 1.72)	0.85
	TT	19	8	2.65 (1.03 – 6.80)	0.04	2.23 (0.85 – 5.84)	0.10
	CT+TT	69	66	1.17 (0.66 – 2.06)	0.60	1.11 (0.62 – 1.98)	0.73
	CC+CT	85	97	1		1
	TT	19	8	2.71 (1.13 – 6.51)	0.03	2.31 (0.95 – 5.64)	0.07
-1985 G>T	GG	36	39	1		1
	GT	49	57	0.93 (0.52 – 1.68)	0.81	0.93 (0.51 – 1.70)	0.81
	TT	19	9	2.29 (0.92 – 5.70)	0.08	1.93 (0.76 – 4.91)	0.17
	GT+TT	68	66	1.12 (0.63 – 1.97)	0.70	1.07 (0.60 – 1.92)	0.81
	GG+GT	85	96	1		1
	TT	19	9	2.38 (1.02 – 5.55)	0.04	2.02 (0.85 – 4.78)	0.11
P1170A C>G	CC	37	37	1		1
	CG	49	58	0.85 (0.47 – 1.53)	0.58	0.84 (0.46 – 1.55)	0.59
	GG	18	10	1.80 (0.73 – 4.42)	0.20	1.57 (0.63 – 3.91)	0.34
	CG+GG	67	68	0.99 (0.56 – 1.74)	0.96	0.96 (0.53 – 1.72)	0.88
	CC+CG	86	95	1		1
	GG	18	10	1.99 (0.87 – 4.54)	0.10	1.73 (0.75 – 4.02)	0.20

OR, odds ratio; CI, confidence interval.

^aasOR are adjusted for age.